Angiomyolipoma future or investigational therapies
Angiomyolipoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Angiomyolipoma future or investigational therapies On the Web |
American Roentgen Ray Society Images of Angiomyolipoma future or investigational therapies |
Angiomyolipoma future or investigational therapies in the news |
Risk calculators and risk factors for Angiomyolipoma future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Faizan Sheraz, M.D. [2],Rekha, M.D.
Overview
Rapamycin and related drugs have been studied for their effect on angiomyolipomas due to their action on the pathways that are disrupted when TSC1 and TSC2 genes are broken.[1]
Future Therapies
Rapamycin
Rapamycin and related drugs have been studied for their effect on angiomyolipomas due to their action on the pathways that are disrupted when TSC1 and TSC2 genes are broken.[1]